#Khattri S, Shemer A, Rozenblit M, et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology [published correction appears in J Allergy Clin Immunol. 2014 Sep;134(3):764]. J Allergy Clin Immunol. 2014;133(6):1626-1634. doi:10.1016/j.jaci.2014.03.003
#Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30. doi:10.1016/j.jid.2016.07.012
#Furue M. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Int J Mol Sci. 2020;21(15):5382. Published 2020 Jul 29. doi:10.3390/ijms21155382
#Criado PR, Miot HA, Bueno-Filho R, Ianhez M, Criado RF, Silva de Castro CC. Update on the pathogenesis of atopic dermatitis. An Bras Dermatol. 2024;99:895–915.
Exclusividade médica
